Biolase patents ophthalmic tech
The US Patent and Trademark Office has issued dental laser manufacturer Biolase Inc. of Irvine, Calif., a patent covering the use of its laser tunneling technologies for treating eye conditions, expanding the application of previous ophthalmic patents granted to Biolase. It includes the architecture and techniques for treating ocular and related tissue sites using laser energy in conjunction with a measuring device capable of determining anatomical structure thickness. Treatment methods covered under the patent include those for the eye conditions presbyopia, glaucoma, retinal disorders and cataracts.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024